| 24/038 |
Use of Biologic Medicines in Dermatology |
| 24/037 |
Guidelines & LocSSIPs for Urology, Stents & Acute Hyperkalaemia |
| 24/036 |
Agency Workforce Spend 01.01.2023 - 31.12.2023 |
| 24/034 |
FGM 01.01.2019 - 31.12.2023 |
| 24/033 |
Safe Staffing Levels |
| 24/030 |
Clinical Insourcing Services January - December 2023 |
| 24/029 |
Translation & Interpretation Costs 2021 - 2023 |
| 24/028 |
Blood Contamination |
| 24/026 |
Induction of Labour |
| 24/025 |
Telephone System Maintenance Contract |
| 24/024 |
On & Off Framework Nursing Agency Usage |
| 24/023 |
Treating Patients with Sodium Nitrite Poisoning |
| 24/022 |
Doctors in Emergency Medicine Department |
| 24/021 |
MS & Immunomodulatory Medications |
| 24/020 |
Lone Worker Technology |
| 24/017 |
Use of Biologic & Biosimilar Products within Rheumatology |
| 24/016 |
Ambulatory ECG Recording |
| 24/015 |
Endourological Procedures 2023 |
| 24/014 |
Palantir Foundry |
| 24/013 |
ID Consumables |
